RDY Net Debt To E B I T D A from 2010 to 2024

RDY Stock  USD 15.37  0.25  1.65%   
Dr Reddys Net Debt To EBITDA yearly trend continues to be fairly stable with very little volatility. Net Debt To EBITDA is likely to outpace its year average in 2024. Net Debt To EBITDA is a leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company's net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). View All Fundamentals
 
Net Debt To EBITDA  
First Reported
2010-12-31
Previous Quarter
0.14628151
Current Value
0.18
Quarterly Volatility
2.81335047
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Dr Reddys financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dr Reddys' main balance sheet or income statement drivers, such as Interest Expense of 1.8 B, Total Revenue of 293.1 B or Gross Profit of 171.8 B, as well as many indicators such as Price To Sales Ratio of 3.91, Dividend Yield of 0.0061 or PTB Ratio of 3.89. RDY financial statements analysis is a perfect complement when working with Dr Reddys Valuation or Volatility modules.
  
Check out the analysis of Dr Reddys Correlation against competitors.

Latest Dr Reddys' Net Debt To E B I T D A Growth Pattern

Below is the plot of the Net Debt To E B I T D A of Dr Reddys Laboratories over the last few years. It is a leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company's net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). Dr Reddys' Net Debt To EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dr Reddys' overall financial position and show how it may be relating to other accounts over time.
Net Debt To E B I T D A10 Years Trend
Slightly volatile
   Net Debt To E B I T D A   
       Timeline  

RDY Net Debt To E B I T D A Regression Statistics

Arithmetic Mean1.31
Coefficient Of Variation215.19
Mean Deviation1.44
Median0.40
Standard Deviation2.81
Sample Variance7.91
Range11.3986
R-Value(0.37)
Mean Square Error7.36
R-Squared0.14
Significance0.18
Slope(0.23)
Total Sum of Squares110.81

RDY Net Debt To E B I T D A History

2024 0.18
2023 0.15
2022 0.1
2021 0.4
2019 0.48
2018 1.13
2017 2.03

About Dr Reddys Financial Statements

Dr Reddys investors use historical fundamental indicators, such as Dr Reddys' Net Debt To E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dr Reddys. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Debt To EBITDA 0.15  0.18 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for RDY Stock Analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.